@naugthy morty
As I said IMHO
The following is the ann from 10 April 2017:
"Mesoblast Limited (ASX: MSB;Nasdaq: MESO) today announced that the Phase 3 trial of its allogeneic mesenchymal precursor cell(MPC) product candidate MPC-150-IM in patients with moderate to advanced chronic heart failure(CHF) was successful in the pre-specified interim futility analysis of the efficacy endpoint in the trial'sfirst 270 patients. It is expected that the trial will enroll in total approximately 600 patients. Afternotifying the Company of the interim analysis results, the trial’s Independent Data MonitoringCommittee (IDMC) additionally stated that they had no safety concerns relating to MPC-150-IM andformally recommended that the trial should continue as planned."
The reference of "pre-specified interim futility analysis of the efficacy endpoint in the trial'sfirst 270 patients", if not mistaken, is referring to statistically significant positive results which admittedly could be for either primary or secondary endpoints.
As you said, if it showed no improvement, they would have asked WOFTAM. That's the purpose of futility analysis.
Yes, no doubt there might be different interpretations of the meaning of the ann. Hence, please do not rely on the above comment/opinion, and do consult your financial advisor for any investment decision.
Finger crossed we all have a prosperous 2020!
- Forums
- ASX - By Stock
- MSB
- Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial
Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial, page-11
-
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.176B |
Open | High | Low | Value | Volume |
95.5¢ | $1.03 | 95.0¢ | $43.38M | 42.28M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 72752 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 205100 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 1.005 |
5 | 57985 | 1.000 |
1 | 50000 | 0.995 |
2 | 20525 | 0.990 |
1 | 10000 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.035 | 190122 | 7 |
1.045 | 39714 | 5 |
1.050 | 21696 | 6 |
1.060 | 9750 | 2 |
1.065 | 5780 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online